迈向消除东非内脏利什曼病作为公共卫生问题:对强化控制策略的反思与行动呼吁
东非是全球内脏利什曼病负担最重的地区,2018年向WHO报告的病例占全球45%,年发病率仅略有下降。该地区缺乏区域性消除策略,而WHO 2021-30路线图目标是将死亡率降至1%以下。本文提出东非协调区域消除的战略框架。
要点
- 东非2018年占全球内脏利什曼病报告病例的45%,年发病率仅略有下降。
- WHO 2021-30路线图目标:将内脏利什曼病死亡率降至1%以下。
- 需在初级卫生保健层面推广诊断和治疗,并实施循证个人防护减少人媒接触。
核心结论
- 为实现WHO 2021-30路线图将东非内脏利什曼病死亡率降至1%以下的目标,需在初级卫生保健层面推广诊断和治疗,并实施循证个人防护方法和减少人媒接触的措施。
- 本文提出东非协调区域消除内脏利什曼病作为公共卫生问题的战略框架。
研究设计与样本
- 本文为卫生政策论文,提出东非协调区域消除内脏利什曼病作为公共卫生问题的战略框架。
主要发现
- 东非是全球内脏利什曼病影响最重的地区,2018年向WHO报告的病例占全球45%,年发病率仅略有下降。
- 与东南亚不同,东非尚无消除内脏利什曼病作为公共卫生问题的区域方法。
- 开发和实施必要工具的投资与合作稀缺。
关键数值与推荐
- WHO 2021-30被忽视热带病路线图目标:将内脏利什曼病所致死亡率降至1%以下。
临床怎么用
- 原文建议在初级卫生保健层面推广诊断和治疗,并实施循证个人防护方法和减少人媒接触的措施。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
East Africa is the world region most affected by visceral leishmaniasis, accounting for 45% of cases globally that were reported to WHO in 2018, with an annual incidence that is only slightly decreasing. Unlike southeast Asia, east Africa does not have a regional approach to achieving elimination of visceral leishmaniasis as a public health problem. The goal of the WHO 2021-30 Neglected Tropical Diseases road map is to reduce mortality caused by the disease to less than 1%. To achieve this goal in east Africa, it will be necessary to roll out diagnosis and treatment at the primary health-care level and implement evidence-based personal protection methods and measures to reduce human-vector contact. Investment and collaboration to develop the necessary tools are scarce. In this Health Policy paper, we propose a strategic framework for a coordinated regional approach in east Africa for the elimination of visceral leishmaniasis as a public health problem.
引用
- Alvar J, den Boer M, Dagne DA, et al. Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflections on an enhanced control strategy and a call for action. Lancet Glob Health. 2021. PMID: 34798033. doi:10.1016/S2214-109X(21)00392-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。